162 related articles for article (PubMed ID: 12064517)
1. Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors.
Ilani T; Fishburn CS; Levavi-Sivan B; Carmon S; Raveh L; Fuchs S
Cell Mol Neurobiol; 2002 Feb; 22(1):47-56. PubMed ID: 12064517
[TBL] [Abstract][Full Text] [Related]
2. Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
Obadiah J; Avidor-Reiss T; Fishburn CS; Carmon S; Bayewitch M; Vogel Z; Fuchs S; Levavi-Sivan B
Cell Mol Neurobiol; 1999 Oct; 19(5):653-64. PubMed ID: 10384262
[TBL] [Abstract][Full Text] [Related]
3. Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells.
Robinson SW; Caron MG
J Neurochem; 1996 Jul; 67(1):212-9. PubMed ID: 8666994
[TBL] [Abstract][Full Text] [Related]
4. Chimeric D2/D3 dopamine receptor coupling to adenylyl cyclase.
Lachowicz JE; Sibley DR
Biochem Biophys Res Commun; 1997 Aug; 237(2):394-9. PubMed ID: 9268722
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG
Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368
[TBL] [Abstract][Full Text] [Related]
6. Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D2 and D3 receptors.
Filteau F; Veilleux F; Lévesque D
FEBS Lett; 1999 Mar; 447(2-3):251-6. PubMed ID: 10214956
[TBL] [Abstract][Full Text] [Related]
7. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
Kozell LB; Machida CA; Neve RL; Neve KA
J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
[TBL] [Abstract][Full Text] [Related]
8. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
Watts VJ; Neve KA
Mol Pharmacol; 1997 Aug; 52(2):181-6. PubMed ID: 9271339
[TBL] [Abstract][Full Text] [Related]
9. Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.
Zaworski PG; Alberts GL; Pregenzer JF; Im WB; Slightom JL; Gill GS
Br J Pharmacol; 1999 Nov; 128(6):1181-8. PubMed ID: 10578130
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells.
McAllister G; Knowles MR; Patel S; Marwood R; Emms F; Seabrook GR; Graziano M; Borkowski D; Hey PJ; Freedman SB
FEBS Lett; 1993 Jun; 324(1):81-6. PubMed ID: 8099332
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.
Robinson SW; Caron MG
Mol Pharmacol; 1997 Sep; 52(3):508-14. PubMed ID: 9281614
[TBL] [Abstract][Full Text] [Related]
12. D2L, D2S, and D3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms.
Liu LX; Monsma FJ; Sibley DR; Chiodo LA
Synapse; 1996 Oct; 24(2):156-64. PubMed ID: 8890457
[TBL] [Abstract][Full Text] [Related]
13. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
Robinson SW; Jarvie KR; Caron MG
Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820
[TBL] [Abstract][Full Text] [Related]
14. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio CL; Lajiness ME; Huff RM
Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
[TBL] [Abstract][Full Text] [Related]
15. Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
Maggio R; Scarselli M; Novi F; Millan MJ; Corsini GU
J Neurochem; 2003 Nov; 87(3):631-41. PubMed ID: 14535946
[TBL] [Abstract][Full Text] [Related]
16. Chimeric dopamine D2/angiotensin AT1 receptors: role of the length of third intracellular loop of D2 receptors in conferring specificity of receptor binding and G-protein coupling.
Chen H; Zhang YY; Han QD
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):209-13. PubMed ID: 10072934
[TBL] [Abstract][Full Text] [Related]
17. Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line.
Pilon C; Lévesque D; Dimitriadou V; Griffon N; Martres MP; Schwartz JC; Sokoloff P
Eur J Pharmacol; 1994 Jul; 268(2):129-39. PubMed ID: 7957635
[TBL] [Abstract][Full Text] [Related]
18. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
Lane JR; Powney B; Wise A; Rees S; Milligan G
J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activity of a chimeric D2/D1 dopamine receptor.
Kozell LB; Neve KA
Mol Pharmacol; 1997 Dec; 52(6):1137-49. PubMed ID: 9396784
[TBL] [Abstract][Full Text] [Related]
20. A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity.
Senogles SE; Heimert TL; Odife ER; Quasney MW
J Biol Chem; 2004 Jan; 279(3):1601-6. PubMed ID: 14581469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
